A A A

News

The latest news and insights on MS.


Illustration showing chat bubbles.

@Momentum

Spring 2015

Readers sound off on diet, winter sports and travel.

pulse_Activists

MS activists rally support

Spring 2015

Every year, more than 325 MS activists from all over the country gather to celebrate advocacy achievements and kick off the year’s federal policy initiatives at the National MS Society’s Public Policy Conference (PPC). The 2015 conference was held near Washington, D.C., from March 9–11.

78783795-forgreg

FDA approves new MS therapy

Spring 2015

A new therapy for use by people with relapsing forms of multiple sclerosis was approved in November 2014 by the U.S. Food and Drug Administration.

Cyndi

Taking the first step

Spring 2015

Walk MS provides connection as well as fuel for the movement.

Photo of man and woman looking at a booklet of information.

It’s open enrollment season

Winter 2014–15

Open enrollment is the time each year when individuals can elect to sign up for or change health insurance plans. The open enrollment “season” is a great time to assess your current medical needs and whether your plan still meets those needs.

Illustration showing chat bubbles.

@Momentum

Winter 2014–15

Readers sound off on medical marijuana, Jack Osbourne and living with MS.

Photo of a woman in winter clothing making a sad face.

Beat the winter blahs

Winter 2014–15

Winter can brew up a “perfect storm” for the blues. For people with MS, the demands of the season may feel even more intense when compounded by disease-related symptoms such as fatigue and depression. Here are some tips to beat the winter blues.

telelearning_fmt

Society telelearning program debuts

Winter 2014–15

The Society’s telelearning series provides information and guidance on current matters essential to living one’s best life with MS. The program offers seven different topics annually. Each free telelearning will feature topic-area expert(s) by phone with online presentations and Q&A session. Presenters are subject to change.

FDA_approvesDiseaseMo_fmt1

FDA approves new disease-modifying therapy

Winter 2014–15

Plegridy (peginterferon beta-1a, manufactured by Biogen Idec) is the newest disease-modifying therapy, or DMT, to be approved by the Food & Drug Administration for relapsing-remitting multiple sclerosis. This makes it the 11th DMT now available to people living with MS.

Cyndi

Maximizing wellness this winter—and beyond

Winter 2014–15

Let’s start a dialogue about how you pursue wellness—and how we can support you.

advertisement